Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemia

This publication has 12 references indexed in Scilit:

• Tumor necrosis factor α modifies resistance to interferon α in vivo: First clinical data
  Cancer Immunology, Immunotherapy, 1992
• Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia
  Blood, 1992
• Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: Initial response and long-term results in 54 patients
  European Journal of Cancer and Clinical Oncology, 1991
• Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gamma
  Blood, 1991
• Interferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous Leukemia
  Annals of Internal Medicine, 1991
• Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration
  Blood, 1988
• Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival
  Blood, 1985
• Prognostic discrimination in "good-risk" chronic granulocytic leukemia
  Blood, 1984
• Long-Term Marrow Culture Reveals Chromosomally Normal Hematopoietic Progenitor Cells in Patients with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia
  New England Journal of Medicine, 1983
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958